Another study demonstrated the ability of CT to potentiate the antitumor effects of doxorubicin on gastric cancer cells through down regulation of STAT3 target genes such as Bcl-xL, Mcl-1, surviving and XIAP [38]. This evidence concerns the gene BCL2L1 and gastric cancer.